Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI

K Kantarci1, R Avula, M L Senjem

  • 1Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. kantarci.kejal@mayo.edu

Neurology
|June 2, 2010
PubMed
Abstract

Insights

Diffusion tensor MRI reveals distinct diffusivity patterns in dementia with Lewy bodies (DLB) and Alzheimer disease (AD). These diffusion measurements complement structural MRI, aiding in the characterization of tissue abnormalities in DLB and AD patients.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Dementia with Lewy bodies (DLB) and Alzheimer disease (AD) are distinct neurodegenerative conditions.
  • Structural MRI is a standard tool for assessing tissue loss in these diseases.
  • Diffusion tensor MRI (DTI) offers insights into white matter integrity and microstructural changes.

Purpose of the Study:

  • To identify unique diffusivity patterns in DLB and AD using DTI.
  • To assess if DTI complements structural MRI in differentiating DLB and AD.
  • To correlate DTI findings with clinical symptoms and disease characteristics.

Main Methods:

  • Case-control study comparing DLB (n=30), AD (n=30), and cognitively normal (CN) (n=60) subjects.
  • 3T DTI with a FLAIR-based sequence for cortical diffusion measurements.
  • Quantification of mean diffusivity (MD) in gray matter and fractional anisotropy (FA) in white matter tracts.

Main Results:

  • DLB patients showed elevated amygdala MD and decreased inferior longitudinal fasciculus (ILF) FA, correlated with hallucinations and parkinsonism.
  • AD patients exhibited elevated MD in medial temporal, temporal, and parietal cortices, with decreased FA in the fornix, cingulum, and ILF.
  • Amygdala diffusivity distinguished DLB from CN; hippocampal/parahippocampal diffusivity distinguished AD from CN, complementing gray matter density.

Conclusions:

  • Increased amygdalar diffusivity in DLB may indicate microvacuolation, a hallmark of Lewy body disease.
  • DTI-derived diffusivity measurements are valuable for characterizing tissue abnormalities in AD and DLB.
  • DTI serves as a complementary tool to structural MRI for diagnosing and differentiating neurodegenerative diseases.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...